SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-24-026722
Filing Date
2024-07-10
Accepted
2024-07-10 07:00:33
Documents
4
Period of Report
2024-07-10

Document Format Files

Seq Description Document Type Size
1 form6-k.htm 6-K 24157
2 ex99-1.htm EX-99.1 24324
3 ex99-1_01.jpg GRAPHIC 7265
4 ex99-1_02.jpg GRAPHIC 45752
  Complete submission text file 0001493152-24-026722.txt   122664
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-41386 | Film No.: 241108665
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)